Helsinki-based VC Maki.vc is poised to reach the final close of its second fund at €100 million, with the aim to invest in seed-stage startups across Europe. The first investments from the new fund include U.K.-based Baseimmune (antigen discovery and vaccine design), Volare (food tech) and PixieRay (adaptive eyeglasses). Maki.vc’s initial ticket sizes range from … Continue reading Helsinki’s Maki.vc poised to close fund at €100M, key focus will be sustainability, deep tech